Arrowhead Research Corp Down Big On Disappointing Hepatitis B Drug Data

By: via Benzinga
Shares of Arrowhead Research Corp (NASDAQ: ARWR) are down sharply following tweets by Adam Feuerstein pointing to disappointing data on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.